Midgard Science
T

Tacalyx

Berlin, Germanytacalyx.comFrom their website, Nov 2026

Work here? Claim this listing

About

Tacalyx GmbH develops novel anticancer therapeutics targeting tumor-associated carbohydrate antigens (TACAs). It is based in Berlin, Germany, and was founded in 2019 as a spin-out of the Max-Planck-Institute of Colloids and Interfaces in Potsdam.

Services

  • Antibody generation

    Generates antibodies for its TACA-targeting programs.

  • Cell-based assays

    Runs cell-based assays to support antibody drug development and pipeline work.

  • Glycobiology

    Performs glycobiology work focused on tumor-associated carbohydrate antigens.

  • Antibody and protein biochemistry

    Carries out antibody and protein biochemistry for therapeutic development.

Capabilities

Assays and studies
  • Antibodies
  • Cell-based assays
  • ADCs
Therapeutic areas
Cancer

Modalities and species

Modalities
  • Antibody
  • ADC

Industries served

  • Biotech

Details

Founded
2019
Based in
Berlin, Germany
Sites
Potsdam, Germany
General enquiry
info@tacalyx.com on their site
Phone
+49 30 407 237 10

Similar labs